Vivera Partners with NINDS of NIH to Identify Potential Stuttering Treatments

Vivera Executes Letter of Intent to Enter a Cooperative Research and Development Agreement with the NINDS of NIH to Assess Therapeutic Agents for Potential Treatments of Stuttering Disorders NEWPORT BEACH, Calif., May 17, 2022 /PRNewswire/ — Vivera Biosciences, a division of Vivera…